John Bissler, MD, recently joined Le Bonheur Children's Hospital as the new chief of pediatric Nephrology.
Bissler comes to Memphis from Cincinnati Children's Hospital Medical Center, where he served as the Clark D. West Chair of Nephrology and associate program director for Research and Academic Careers.
medical training at Northeastern Ohio University College of Medicine
residency in pediatrics at Children's Medical Center
, Akron, and his
nephrology fellowship at Cincinnati Children's.
Board certified in pediatrics and nephrology in Memphis, Bissler also serves as a professor at the University of Tennessee Health Science Center.
research interests include proliferative renal diseases, polycystic kidney disease, tuberous sclerosis complex, Von Hippel-Lindau disease, Birt Hogg-Dube syndrome and renal cancers.
Bissler replaces Robert Wyatt, MD, who retired as chief after 29 years in the division.
Everolimus - a rapamycin derivative - could be a potential treatment for angiomyolipomas associated with tuberous sclerosis complex (TSC), according to a study recently published in The Lancet by Le Bonheur Nephrologist John Bissler, MD.
John Bissler, MD, chief of Nephrology, will serve as director of the center with Pediatric Neurologist James Wheless, MD, who will serve as co-director.